Amir Emamifar, PharmD, MBA, Vice President and Chief Pharmacy Officer at Temple University Health System, spoke with Becker’s Hospital Review about pharmacy burnout.
Amir Emamifar, PharmD, MBA, Vice President and Chief Pharmacy Officer at Temple University Health System, spoke with Becker’s Hospital Review about pharmacy burnout.
Patients who received tezepelumab vs. placebo had less healthcare resource utilization; and fewer patients on tezepelumab vs. placebo received systemic corticosteroids for COPD exacerbations.
Read MoreThe analysis looked at sotatercept use in patients with pulmonary arterial hypertension and the safety and utilization across phenotype groups.
Read More